Market Cap 54.24M
Revenue (ttm) 32.03M
Net Income (ttm) -13.97M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -43.62%
Debt to Equity Ratio -3.87
Volume 125,018
Avg Vol 61,304
Day's Range N/A - N/A
Shares Out 8.08M
Stochastic %K 32%
Beta 0.59
Analysts Strong Sell
Price Target $19.25

Company Profile

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It...

Industry: Medical Devices
Sector: Healthcare
Phone: 888 903 2673
Fax: 973 290 9171
Address:
200 Forge Way, Suite 205, Rockaway, United States
Reacting
Reacting Apr. 9 at 3:13 PM
0 · Reply
Digitalization2026
Digitalization2026 Apr. 9 at 2:43 PM
0 · Reply
Mudloaf
Mudloaf Apr. 9 at 1:42 PM
$ECOR 54k shares traded first 10 min hmm
0 · Reply
Mudloaf
Mudloaf Apr. 8 at 8:02 PM
$ECOR this board is so dead. What are ppl looking for to spark this thing again? It’s ready to ignite if something provided a spark.
1 · Reply
focafoca99
focafoca99 Apr. 8 at 8:01 PM
$ECOR is another Needham conference appearance with management participating in the event.
0 · Reply
focafoca99
focafoca99 Apr. 7 at 9:32 PM
$ECOR says the first eight patients have been enrolled in an investigator-led PTSD study using gammaCore nVNS.
0 · Reply
taxplanr
taxplanr Apr. 7 at 5:06 PM
$ECOR PTSD 12 week study started with 8 patients https://investor.electrocore.com/news-releases/news-release-details/electrocore-announces-first-patient-enrollment-investigator-led
0 · Reply
DARKP00L
DARKP00L Apr. 7 at 12:17 PM
$ECOR 08:12 on Apr. 07 2026 electroCore Begins Patient Enrollment In gammaCore nVNS Treatment For PTSD Study #tradeideas
0 · Reply
TheTradeXchange
TheTradeXchange Apr. 7 at 12:02 PM
$ECOR - electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
0 · Reply
taxplanr
taxplanr Apr. 2 at 1:52 PM
$ECOR CFO and interim CEO buys stock https://investor.electrocore.com/node/12016/html
1 · Reply
Latest News on ECOR
electroCore Expands Intellectual Property Portfolio

Mar 30, 2026, 8:00 AM EDT - 10 days ago

electroCore Expands Intellectual Property Portfolio


electroCore to Participate at the 38th Annual Roth Conference

Mar 10, 2026, 8:00 AM EDT - 4 weeks ago

electroCore to Participate at the 38th Annual Roth Conference


electroCore Announces Third Quarter 2025 Financial Results

Nov 5, 2025, 4:05 PM EST - 5 months ago

electroCore Announces Third Quarter 2025 Financial Results


electroCore Appoints Elena Bonfiglioli to Board of Directors

Sep 3, 2025, 8:00 AM EDT - 7 months ago

electroCore Appoints Elena Bonfiglioli to Board of Directors


electroCore Announces Second Quarter 2025 Financial Results

Aug 6, 2025, 4:05 PM EDT - 8 months ago

electroCore Announces Second Quarter 2025 Financial Results


electroCore to Participate in Upcoming Investor Conferences

Jul 22, 2025, 4:05 PM EDT - 9 months ago

electroCore to Participate in Upcoming Investor Conferences


electroCore Announces First Quarter 2025 Financial Results

May 7, 2025, 4:05 PM EDT - 1 year ago

electroCore Announces First Quarter 2025 Financial Results


electroCore's Truvaga™ Now Works with the Apple Health app

May 1, 2025, 8:00 AM EDT - 1 year ago

electroCore's Truvaga™ Now Works with the Apple Health app


electroCore to Participate at the Planet MicroCap Showcase

Apr 16, 2025, 8:00 AM EDT - 1 year ago

electroCore to Participate at the Planet MicroCap Showcase


electroCore Extends VA Contract for Five Years

Mar 31, 2025, 8:00 AM EDT - 1 year ago

electroCore Extends VA Contract for Five Years


electroCore Announces Full Year 2024 Financial Results

Mar 12, 2025, 4:05 PM EDT - 1 year ago

electroCore Announces Full Year 2024 Financial Results


electroCore to Participate at Upcoming Investor Conferences

Mar 5, 2025, 8:00 AM EST - 1 year ago

electroCore to Participate at Upcoming Investor Conferences


electroCore Announces Third Quarter 2024 Financial Results

Nov 13, 2024, 4:01 PM EST - 1 year ago

electroCore Announces Third Quarter 2024 Financial Results


electroCore to Participate at LD Micro Main Event VXII

Oct 14, 2024, 8:00 AM EDT - 1 year ago

electroCore to Participate at LD Micro Main Event VXII


electroCore Announces Second Quarter 2024 Financial Results

Aug 7, 2024, 4:01 PM EDT - 1 year ago

electroCore Announces Second Quarter 2024 Financial Results


electroCore Announces the Commercial Launch of TAC-STIM™

Jun 25, 2024, 8:00 AM EDT - 1 year ago

electroCore Announces the Commercial Launch of TAC-STIM™


Reacting
Reacting Apr. 9 at 3:13 PM
0 · Reply
Digitalization2026
Digitalization2026 Apr. 9 at 2:43 PM
0 · Reply
Mudloaf
Mudloaf Apr. 9 at 1:42 PM
$ECOR 54k shares traded first 10 min hmm
0 · Reply
Mudloaf
Mudloaf Apr. 8 at 8:02 PM
$ECOR this board is so dead. What are ppl looking for to spark this thing again? It’s ready to ignite if something provided a spark.
1 · Reply
focafoca99
focafoca99 Apr. 8 at 8:01 PM
$ECOR is another Needham conference appearance with management participating in the event.
0 · Reply
focafoca99
focafoca99 Apr. 7 at 9:32 PM
$ECOR says the first eight patients have been enrolled in an investigator-led PTSD study using gammaCore nVNS.
0 · Reply
taxplanr
taxplanr Apr. 7 at 5:06 PM
$ECOR PTSD 12 week study started with 8 patients https://investor.electrocore.com/news-releases/news-release-details/electrocore-announces-first-patient-enrollment-investigator-led
0 · Reply
DARKP00L
DARKP00L Apr. 7 at 12:17 PM
$ECOR 08:12 on Apr. 07 2026 electroCore Begins Patient Enrollment In gammaCore nVNS Treatment For PTSD Study #tradeideas
0 · Reply
TheTradeXchange
TheTradeXchange Apr. 7 at 12:02 PM
$ECOR - electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
0 · Reply
taxplanr
taxplanr Apr. 2 at 1:52 PM
$ECOR CFO and interim CEO buys stock https://investor.electrocore.com/node/12016/html
1 · Reply
History101
History101 Apr. 1 at 7:42 PM
$ELAB $ERAS $EDSA i forgot $EEIQ & $ECOR!!
1 · Reply
taxplanr
taxplanr Apr. 1 at 2:11 PM
$ECOR Published findings for Traumatic Brain Injury and PTSD https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2026.1808542/abstract
0 · Reply
DARKP00L
DARKP00L Apr. 1 at 12:08 PM
$ECOR 08:02 on Apr. 01 2026 electroCore Announces New Clinical Findings Published That Demonstrates Potential Benefits Of Adjunctive Non-invasive Vagus Nerve Stimulation In Patients With Chronic Mild Traumatic Brain Injury And Comorbid Post-traumatic Stress Disorder #tradeideas
0 · Reply
DARKP00L
DARKP00L Mar. 30 at 12:12 PM
$ECOR 08:04 on Mar. 30 2026 electroCore Announces Issuance Of Two New Additions To U.S. Patent Portfolio #tradeideas
0 · Reply
cgcapitalresearch
cgcapitalresearch Mar. 24 at 2:19 PM
$ECOR : Q4/FY2025 Results Beat Consensus; Platform Story Comes Into Focus as Revenue Hits Record $32M - We raise our price target to $22.00 (from $20.00) and reiterate our Outperform rating on electroCore, Inc. (NASDAQ: ECOR) following a clean Q4/FY2025 earnings beat. The company delivered record quarterly revenue of $9.2 million (+31% YoY) and record full-year revenue of $32.0 million (+27% YoY), exceeding both our estimates and the Street consensus across key metrics. Importantly, gross margin came in at 87% for the full year — 100 basis points above our model — reflecting durable product mix strength and growing operating discipline. READ MORE: https://hubs.ly/Q048477S0
0 · Reply
taxplanr
taxplanr Mar. 20 at 2:02 PM
$ECOR Chairman bought more stock before quarterly report yesterday https://investor.electrocore.com/node/11996/html
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Mar. 19 at 9:14 PM
$ECOR Q4 '25 Earnings Results & Recap ElectroCore Inc reported net sales of $32M for the year ended December 31, 2025, an increase from $25.2M in 2024, with gross profit rising to $27.8M and gross margin at 87%.
0 · Reply
taxplanr
taxplanr Mar. 19 at 8:27 PM
$ECOR Truvaga/Plus sales nearly doubled If that pace continues ... 🚀
0 · Reply
AaronRho
AaronRho Mar. 19 at 8:22 PM
$ECOR I’ll be listening in! Looks like they may break even next year if they hit their targets.
0 · Reply
Mudloaf
Mudloaf Mar. 19 at 7:22 PM
$ECOR risk seems asymmetrical to the upside
0 · Reply
1621CAPITAL
1621CAPITAL Mar. 16 at 7:02 PM
0 · Reply
cgcapitalresearch
cgcapitalresearch Mar. 13 at 5:31 PM
$ECOR Earnings Preview — Revenue Momentum Across VA and Wellness Channels: We maintain our Outperform rating and $20 price target on electroCore, Inc. (NASDAQ: ECOR) as the commercial-stage bioelectronic medicine company approaches a key inflection point driven by accelerating revenue momentum, improving operating leverage, and expanding clinical applications for its non-invasive vagus nerve stimulation (nVNS) platform. Read more: https://hubs.ly/Q046MpXP0
0 · Reply